We are live on ! Find out more
CAG

Csenge Advisory Group Portfolio holdings

AUM $2.18B
1-Year Est. Return 16.73%
This Fund
S&P 500
This Quarter Est. Return
+0.78%
1 Year Est. Return
+16.73%
3 Year Est. Return
+51.88%
5 Year Est. Return
+54.25%
10 Year Est. Return
AUM
$2.18B
AUM Growth
-$25.8M
Cap. Flow
-$21.9M
Cap. Flow %
-1%
Top 10 Hldgs %
33.46%
Holding
822
New
110
Increased
282
Reduced
332
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 6.12%
2 Financials 2.92%
3 Consumer Discretionary 2.47%
4 Industrials 2.45%
5 Healthcare 2.26%

No holdings matched the selected filter criteria.

Similar funds

Csenge Advisory Group's Q1 2026 Portfolio in Review

As of Q1 2026, Csenge Advisory Group held 822 positions worth $2.18B, down 1.2% from $2.21B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Csenge Advisory Group's Q1 2026 filing shows 110 new, 282 increased, 332 reduced and 75 closed positions. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 31,620 shares worth $6.35M. The largest sale was First Trust Morningstar Dividend Leaders Index Fund, an estimated $15.5M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 6.9% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Csenge Advisory Group's largest Q1 2026 buy was First Trust NYSE Arca Biotechnology Index Fund: 31,620 shares worth $6.35M.
  • Csenge Advisory Group added most to Invesco S&P 500 Equal Weight ETF in Q1 2026, an estimated $5.53M increase.
  • Csenge Advisory Group's biggest Q1 2026 reduction was First Trust Morningstar Dividend Leaders Index Fund, cutting an estimated $15.5M.
  • Csenge Advisory Group fully exited KraneShares CSI China Internet ETF in Q1 2026, selling an estimated $5.16M.
  • Csenge Advisory Group's ten largest holdings make up 33% of its $2.18B portfolio in Q1 2026.
  • Csenge Advisory Group opened 110 new positions and closed 75 in Q1 2026.
  • Csenge Advisory Group's portfolio value fell 1.2% quarter-over-quarter to $2.18B.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.